The Ministry of Health, through the Pharmacy and Poisons Board (PPB), has issued a warning regarding a falsified batch of Avastin (Bevacizumab 100 mg) injection circulating in the Kenyan market. This critical cancer drug has been identified as counterfeit, prompting an urgent alert to healthcare providers and the public.

• The falsified product is identified by Batch Number H0573B01 and falsely claims to be manufactured by Roche.
• Dr. A. Mohamed, Chief Executive Officer at the Ministry of Health, urged all stakeholders to report any cases involving this batch and to source Health Products and Technologies (HPTs) only from licensed entities.
• Legal and regulatory actions will be taken against those involved in the circulation of this falsified batch, under the Pharmacy and Poisons Act (CAP 244).